Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02030067
Title Dose-Finding and Safety Study for Oral Single-Agent to Treat Advanced Malignancies
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Rexahn Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Rexahn Site Birmingham Alabama 35294 United States Details
Rexahn Site Tucson Arizona 85724 United States Details
Rexahn Site Duarte California 91010 United States Details
Rexahn Site Miami Lakes Florida 33014 United States Details
Rexahn Site Miami Florida 33136 United States Details
Rexahn Site Skokie Illinois 60077 United States Details
Rexahn Site Saint Louis Missouri 63110 United States Details
Rexahn Site Las Vegas Nevada 89119 United States Details
Rexahn Site New York New York 10021 United States Details
Rexahn Site San Antonio Texas 78229 United States Details
Rexahn Site Salt Lake City Utah 84112 United States Details
Rexahn Site Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field